单次阳性组织培养增加临床无菌性全髋关节置换翻修术后再翻修风险:一项全国登记研究
该登记研究纳入丹麦髋关节置换登记中2010年1月至2016年5月所有首次无菌性松动翻修术,共2305例,其中91%术中取培养。282例(12%)出现意外阳性培养。与培养阴性相比,单次阳性培养的全因再翻修风险(RR 1.73,95%CI 1.07-2.80,p=0.020)和假体周围感染(PJI)再翻修风险(RR 2.63,95%CI 1.16-5.96,p=0.020)均升高;两次及以上阳性组无显著差异。
要点
- 首次临床无菌性全髋翻修中12%出现意外阳性培养,单次阳性与全因再翻修风险升高相关(RR 1.73)。
- 单次阳性培养的PJI再翻修风险亦升高(RR 2.63,95%CI 1.16-5.96,p=0.020)。
- 两次及以上阳性培养组再翻修风险未达统计学显著,但门诊抗生素处方更频繁(45% vs 17%,p<0.001)。
核心结论
- 首次临床无菌性全髋翻修术中单次培养意外阳性与全因再翻修和PJI再翻修风险升高相关。
- 后期再翻修病例中主要细菌为凝固酶阴性葡萄球菌。
- 即使五次活检培养中仅一次阳性,常见细菌的意外生长也可能有临床重要性。
研究设计与样本
- 基于丹麦髋关节置换登记(DHR)的登记研究,纳入2010年1月至2016年5月所有首次无菌性松动翻修术,共2305例。
- DHR数据与丹麦微生物数据库合并,91%(2090/2305)的无菌翻修术取了术中培养。
- 按同一菌属阳性培养数分为零次、一次、两次及以上三组,随访至再翻修、死亡或1年随访期结束。
- 证据等级:Level III,治疗性研究。
主要发现
- 282例(12%)出现意外阳性培养,其中170例(60%)仅一次培养阳性或混合微生物生长。
- 凝固酶阴性葡萄球菌为主要细菌,见于121例(71%)。
- 163例(7%)行再翻修,其中43例(26%)再翻修指征为PJI。
- 与培养阴性相比,单次阳性组全因再翻修风险升高(RR 1.73,95%CI 1.07-2.80,p=0.020),两次及以上阳性组无显著差异(RR 1.52,95%CI 0.82-2.80,p=0.180)。
- 单次阳性组PJI再翻修风险升高(RR 2.63,95%CI 1.16-5.96,p=0.020),两次及以上阳性组无显著差异(RR 2.28,95%CI 0.81-6.43,p=0.120)。
关键数值与推荐
- 意外阳性培养定义为:报告为无菌性翻修的全髋术后观察到的阳性培养。
- 门诊抗生素处方:两次及以上阳性组50/112(45%)vs 培养阴性组353/2023(17%),p<0.001。
- 门诊抗生素处方:单次阳性组36/170(21%)vs 培养阴性组353/2023(17%),p=0.220。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The diagnostic and prognostic value of unexpected positive intraoperative cultures remains unclear in diagnosing prosthetic joint infection (PJI) in THA revisions. QUESTIONS/PURPOSES: Therefore, we asked: (1) What is the clinical importance of bacterial growth in intraoperative tissue cultures taken during first-time revision of a clinically aseptic THA in terms of all-cause rerevision and rerevision for PJI specifically? (2) Is there a difference in outpatient antibiotic treatment patterns that is dependent on the number of positive intraoperative cultures? METHODS: This register-based study included all procedures reported to the Danish Hip Arthroplasty Register (DHR) as first-time aseptic loosening revisions performed during January 2010 to May 2016. DHR data were merged with that of the Danish Microbiology Database, which contains data from all intraoperatively obtained cultures in Denmark. Both registers have been validated and have a very high degree of completeness and very few patients are missing as a result of emigration. Revisions were grouped based on the number of unexpected positive cultures growing the same bacterial genus: zero, one, or two or more cultures. We defined a positive culture as "unexpected" if it was observed after a revision THA that had been reported to the DHR as aseptic. In Denmark, cultures are routinely obtained even in revisions coded as aseptic, and in this report, 91% (2090 of 2305) of the revision THAs coded as aseptic had cultures taken. The revisions were followed until rerevision, death, or end of the 1-year followup period. The relative risk for rerevision resulting from all causes and PJI was estimated. The Danish National Prescription Registry was reviewed for outpatient antibiotic prescription within 6 weeks of revision. We included 2305 first-time aseptic revisions. Unexpected growth was found in 282 THAs (12%), of which 170 (60%) had growth in only one culture or mixed microbial growth. Coagulase-negative Staphylococcus was the dominating bacteria in 121 revisions (71%). Rerevision was performed on 163 THAs (7%) with PJI being the indication for rerevision in 43 THAs (26%). RESULTS: The risk of all-cause rerevision was greater among first-time revisions with one positive culture (relative risk [RR], 1.73; 95% confidence interval [CI], 1.07-2.80; p = 0.020), but not in the two or more positive group (RR, 1.52; 95% CI, 0.82-2.80; p = 0.180) when compared with the culture-negative THAs. First-time revisions with one positive culture also had a higher risk of rerevision for PJI specifically (RR, 2.63; 95% CI, 1.16-5.96; p = 0.020), but this was not the case in the two or more positive group (RR, 2.28; 95% CI, 0.81-6.43; p = 0.120). Outpatient antibiotic prescription was more frequent after revisions with two or more positive cultures compared with culture-negative revision (50 of 112 [45%] versus 353 of 2023 [17%]; p < 0.001). This was not the case in revisions with one positive culture (36 of 170 [21%] versus 353 of 2023 [17%]; p = 0.220). CONCLUSIONS: First-time clinically aseptic THA revisions with unexpected growth in one biopsy culture had an increased risk for rerevision, both in terms of all-cause revision and revision for PJI. The predominant bacteria in revisions with later rerevision was coagulase-negative Staphylococcus. This emphasizes that unexpected bacterial growth with common bacteria may be clinically important, even if only one of five biopsy cultures is positive. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Milandt NR, Gundtoft PH, Overgaard S, et al. A Single Positive Tissue Culture Increases the Risk of Rerevision of Clinically Aseptic THA: A National Register Study. Clin Orthop Relat Res. 2019. PMID: 31136437. doi:10.1097/CORR.0000000000000609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。